Company Filing History:
Years Active: 2021-2025
Title: Cendrine Grangeon: Innovator in Pharmaceutical Compositions
Introduction
Cendrine Grangeon is a notable inventor based in Lyons, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance the pharmacokinetics of certain compounds. With a total of seven patents to her name, her work is recognized for its innovative approach to improving drug efficacy.
Latest Patents
Among her latest patents, Cendrine has developed oral pharmaceutical compositions of sodium oxybate that exhibit improved pharmacokinetic properties when administered less than two hours after eating. This advancement is crucial for optimizing therapeutic outcomes in patients. Her work on gamma-hydroxybutyrate compositions also focuses on enhancing pharmacokinetics in the fed state, showcasing her commitment to advancing medical treatments.
Career Highlights
Cendrine is currently associated with Flamel Ireland Limited, where she continues to push the boundaries of pharmaceutical innovation. Her expertise in drug formulation and pharmacokinetics has positioned her as a key player in her field.
Collaborations
Cendrine collaborates with talented individuals such as Julien Grassot and Jordan Dubow, contributing to a dynamic team that fosters innovation and research in pharmaceutical sciences.
Conclusion
Cendrine Grangeon exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patents and collaborations are paving the way for improved therapeutic solutions.